ロード中...

EPID-06. IMMUNE-RELATED PLASMA BIOMARKERS IN GLIOBLASTOMA

BACKGROUND: Glioblastoma (GBM) is an aggressive and malignant primary brain tumor with limited treatment options and a dismal prognosis. Immunotherapy is advancing in other types of cancer but has not yet proven effective in glioblastoma. Prognostic and predictive biomarkers and new treatment target...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Bjørnbak Holst, Camilla, Jarle Christensen, Ib, Skjoeth-Rasmussen, Jane, Skovgaard Poulsen, Hans, Hamerlik, Petra, Sidenius Johansen, Julia
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847709/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.306
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!